A new study published in the Journal of Clinical Investigation found that COVID was linked to cancer regression, which could ...

Merck & Co. Inc.'s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer drug Keytruda. Rahway, N.J.-based Merck (MRK) said a trial of the drug, given ...

A small trial of an experimental vaccine has shown promising results for patients with the most aggressive type of breast ...

RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more ...

Today's health news includes how RFK Jr. could strip legal protections from vaccine makers and why more young people are getting cancer.

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

An experimental vaccine showed promise in treating aggressive breast cancer, while a new gene therapy method advances ...

After surgery, the team analyzed and compared the tumor tissue with the healthy tissue of the same patient to find unique ...

Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with ...

A new vaccine is offering hope for people fighting an aggressive form of breast cancer. Dr. Michael Daignault talks about ...